Skip to content
Stocks News
Enter Ticker Symbol
  • Home
  • FEATURED COMPANY
  • ANALYST COVERAGE
  • NEWS
  • SUBSCRIBE
  • CONTACT

ANALYST COVERAGE

recent-analyst-ratings-forecast-further-upside-for-tat-technologies-ltd.-(tatt)

Recent Analyst Ratings Forecast Further Upside For TAT Technologies Ltd. (TATT)

Jul 22, 2025

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is…

Read more
top-analyst-reports-for-philip-morris,-mcdonald’s-&-texas-instruments

Top Analyst Reports for Philip Morris, McDonald’s & Texas Instruments

Jul 22, 2025

Monday, July 21, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today’s…

Read more
top-analyst-reports-for-philip-morris,-mcdonald’s-&-texas-instruments

Top Analyst Reports for Philip Morris, McDonald’s & Texas Instruments

Jul 22, 2025

Monday, July 21, 2025 The Zacks Research Daily presents the best research output of our analyst team. Today’s Research…

Read more
espn-makes-decision-about-richard-jefferson’s-future-on-nba-coverage

ESPN Makes Decision About Richard Jefferson’s Future on NBA Coverage

Jul 21, 2025

Months after being promoted to ESPN’s top NBA broadcast team in the middle of the 2024–25 season, Richard…

Read more
truist-securities-initiates-biogen-stock-coverage-with-hold-rating-by-investing.com

Truist Securities initiates Biogen stock coverage with Hold rating By Investing.com

Jul 21, 2025

Truist Securities initiates Biogen stock coverage with Hold rating

Read more
amd-stock-rallies-as-bernstein analyst-raises-price-target

AMD Stock Rallies as Bernstein Analyst Raises Price Target

Jul 21, 2025

An error has occurred Your request was blocked by Link11 Web Application Security.If you believe this is the…

Read more
bridgebio-pharma-stock-(bbio)-opinions-on-analyst-buy-ratings-and-attruby-launch

BridgeBio Pharma Stock (BBIO) Opinions on Analyst Buy Ratings and Attruby Launch

Jul 21, 2025

By: Quiver DiscussionTracker Posted: an hour ago / July 21, 2025 5:01 p.m. UTC Recent discussions on X…

Read more
loop-capital-initiates-coverage-on-autodesk-stock-with-hold-rating-by-investing.com

Loop Capital initiates coverage on Autodesk stock with Hold rating By Investing.com

Jul 21, 2025

Loop Capital initiates coverage on Autodesk stock with Hold rating

Read more
expanding-analyst-interest-in-oryzon

Expanding Analyst Interest in ORYZON

Jul 21, 2025

New U.S. investment bank joins, bringing total coverage to ten analysts MADRID and CAMBRIDGE, Mass., July 21, 2025…

Read more
recent-analyst-ratings-forecast-further-upside-for-tat-technologies-ltd.-(tatt)

Recent Analyst Ratings Forecast Further Upside For TAT Technologies Ltd. (TATT)

Jul 21, 2025

Ashar Jawad Mon, Jul 21, 2025, 8:03 AM 2 min read In This Article: TAT Technologies Ltd. (NASDAQ:TATT)…

Read more
iqst-–-iqstel-issues-recap-shareholder-letter-highlighting-$2-debt-reduction-per-share,-$400-million-run-rate-in-q3-(ahead-of-schedule),-and-analyst-coverage-targeting-$18-$22-price-range

IQST – IQSTEL Issues Recap Shareholder Letter Highlighting $2 Debt Reduction Per Share, $400 Million Run Rate in Q3 (Ahead of Schedule), and Analyst Coverage Targeting $18-$22 Price Range

Jul 21, 2025

Company Recaps Milestones After Two Months onNASDAQ: Accelerated Growth, Strengthened Balance Sheet, Launch of High-Margin Tech Products, and…

Read more
this-alnylam-pharmaceuticals-analyst-begins-coverage-on-a-bullish-note;-here-are-top-5-initiations-for-monday-–-autodesk-(nasdaq:adsk),-albertsons-companies-(nyse:aci)

This Alnylam Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday – Autodesk (NASDAQ:ADSK), Albertsons Companies (NYSE:ACI)

Jul 21, 2025

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst…

Read more
  1. Pages:
  2. «
  3. 1
  4. ...
  5. 260
  6. 261
  7. 262
  8. 263
  9. 264
  10. 265
  11. 266
  12. ...
  13. 469
  14. »

Posts pagination

Newer posts Page 1 … Page 263 … Page 469 Older posts

The content presented on this site is intended solely for entertainment purposes and should not be construed as an invitation to engage in the purchase or sale of securities. Each content provider featured on 10x Wealth Report brings a unique perspective and predisposition, which may not necessarily align with that of 10x Wealth Report. It is crucial to recognize that 10x Wealth Report is not a registered financial advisor or firm. Read More full disclaimer

CATEGORIES

  • FEATURED COMPANY
  • NEWS
  • ANALYST COVERAGE
  • Special Post
  • CONTACT
  • SUBSCRIBE
  • Privacy Policy
  • Terms or Service
  • Disclaimer

CONNECT & FOLLOW

© 10x Wealth Report Copyright 2024.